Sotac Pharmaceuticals Limited (NSE:SOTAC)

India · Delayed Price · Currency is INR

100.00

-0.50 (-0.50%)

Jul 13, 2026, 2:50 PM IST

-26.79% (1Y)

Market Cap	1.11B -14.2%
Revenue (ttm)	1.02B +1.3%
Net Income	57.67M -28.2%
EPS	5.22 -28.1%
Shares Out	11.05M
PE Ratio	19.16
Forward PE	n/a
Dividend	0.20 (0.20%)
Ex-Dividend Date	n/a

Volume	2,400
Open	100.00
Previous Close	100.50
Day's Range	100.00 - 100.00
52-Week Range	100.00 - 139.65
Beta	-0.02
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About Sotac Pharmaceuticals

Sotac Pharmaceuticals Limited engages in the production, manufacturing, processing, and sale of various pharmaceutical products in India. Its therapeutic product portfolio includes anti-diabetic, anti-psychotic, vitamins, minerals, iron supplements, anti-cold, anti-allergic, dermatological solutions, antacid, anti-ulcerants, PPI, anti-emetics, cardiac, anti-hypertensives, analgesic, anti-pyretic, anti-inflammatory, anti-bacterial, anti-viral, general antibiotics, IP-lactams and non-IP-lactams, anti-fungal, and cephalosporin products. The compan... [Read more]

Industry Medical - Pharmaceuticals

Sector Healthcare

Founded 2014

Employees 127

Stock Exchange National Stock Exchange of India

Ticker Symbol SOTAC

Full Company Profile

Financial Performance

In fiscal year 2026, Sotac Pharmaceuticals's revenue was 1.02 billion, an increase of 1.33% compared to the previous year's 1.00 billion. Earnings were 57.67 million, a decrease of -28.16%.

Financial Statements